AGED Diagnostics is developing a blood test for liver disease (NASH) using genomic innovation to improve early detection and intervention.

AGED Diagnostics

Google

Google Cloud

Microsoft Personal Web Server

Rachel Zayas

Founder, CEO

Medical Companies With Fewer Than 10 Employees (Top 10K)

Southern US Health Care Companies (Top 10K)

Washington DC Metro Area Companies (Top 10K)

Private Washington DC Metro Area Companies (Top 10K)

AGE Diagnostics develops diagnostic tools for nonalcoholic steatohepatitis (NASH, liver disease) and fibrosis (liver scarring). AGED tools can simultaneously stage fibrosis and distinguish benign from severe liver disease (liver scarring). This method measures the concentration of target biomarkers (genetic signatures) in circulation using a targeted genomic sequencing assessment. When biomarkers are detected over a specific quantity, liver disease (NASH) and/or fibrosis are diagnosed.

Washington

District of Columbia

United States

North America

Methods and compositions for treating liver cancer and liver disease

A blood test designed to detect liver disease, including nonalcoholic steatohepatitis (NASH) and fibrosis, by measuring the concentration of specific genetic biomarkers in circulation.

A targeted genomic sequencing method used to differentiate between benign and advanced liver disease and to stage fibrosis by analyzing genetic signatures.

A technique that combines gene expression analysis with spatial information to study gene expression patterns in liver tissue, aiding in the identification of novel biomarkers and understanding disease pathology.

Research focused on the role of epigenetic modifications, such as DNA methylation and histone modifications, in the development and progression of liver diseases, providing insights into potential therapeutic targets.

AGED Diagnostics is developing blood tests for liver disease, specifically nonalcoholic steatohepatitis (NASH), using genomic innovation to improve patient outcomes through early detection.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 17, 2024 9:32 PM	181eb297
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 17, 2024 9:32 PM	504aff52
crunchbase trigger	general	Nov 17, 2024 9:32 PM	2dbbe576
crunchbase profile	general	Nov 18, 2024 3:20 AM	be9f5175
li profile	general	Nov 17, 2024 9:32 PM	79fb292d
translate crunchbase fundingrounds	general	Nov 18, 2024 3:44 AM	01e6420b
peers	general	Nov 17, 2024 9:32 PM	a7427ef9
news basic	general	Nov 17, 2024 9:32 PM	17ddabaf
bundesanzeiger	filings
financials download nd	financials
private financials	financials

AGED

COM:AGEDDIAGNOSTICS

AGED Diagnostics